Sign up
Pharma Capital

Venture Life has sights set on expanding presence in US market

Jerry Randall, chief executive of Venture Life Group Plc (LON:VLG) tells Proactive they developed some new products last year which will be launching into the market this year.

''We're also looking to acquire more products ... we've successfully acquired a number of products over the year and we're now at the stage where we've got a platform that has good operating leverage .... so new products and revenues we put through, the majority of that gross margin will fall through to the net margin level'''.


View full VLG profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.